P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism

S. Al-Bahlani, M. Fraser, A. Y C Wong, B. S. Sayan, R. Bergeron, G. Melino, B. K. Tsang

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

P73 is important in drug-induced apoptosis in some cancer cells, yet its role in the regulation of chemosensitivity in ovarian cancer (OVCA) is poorly understood. Furthermore, if and how the deregulation of p73-mediated apoptosis confers resistance to cisplatin (CDDP) treatment is unclear. Here we demonstrate that TAp73α over-expression enhanced CDDP-induced PARP cleavage and apoptosis in both chemosensitive (OV2008 and A2780s) and their resistant counterparts (C13 and A2780cp) and another chemoresistant OVCA cells (Hey); in contrast, the effect of ΔNp73α over-expression was variable. P73α downregulation attenuated CDDP-induced PUMA and NOXA upregulation and apoptosis in OV2008 cells. CDDP decreased p73α steady-state protein levels in OV2008, but not in C13, although the mRNA expression was identical. CDDP-induced p73α downregulation was mediated by a calpain-dependent pathway. CDDP induced calpain activation and enhanced its cytoplasmic interaction and co-localization with p73α in OV2008, but not C13 cells. CDDP increased the intracellular calcium concentration ([Ca 2[ i) in OV2008 but not C13 whereas cyclopiazonic acid (CPA), a Ca 2+-ATPase inhibitor, caused this response and calpain activation, p73α processing and apoptosis in both cell types. CDDP-induced [Ca 2+[ i increase in OV2008 cells was not effected by the elimination of extracellular Ca 2+, but this was attenuated by the depletion of internal Ca 2+ store, indicating that mobilization of intracellular Ca 2+] stores was potentially involved. These findings demonstrate that p73α and its regulation by the Ca 2+-mediated calpain pathway are involved in CDDP-induced apoptosis in OVCA cells and that dysregulation of Ca 2+/calpain/p73 signaling may in part be the pathophysiology of CDDP resistance. Understanding the cellular and molecular mechanisms of chemoresistance will direct the development of effective strategies for the treatment of chemoresistant OVCA.

Original languageEnglish
Pages (from-to)4219-4230
Number of pages12
JournalOncogene
Volume30
Issue number41
DOIs
Publication statusPublished - Oct 13 2011

Fingerprint

Calpain
Ovarian Neoplasms
Cisplatin
Apoptosis
Calcium
Down-Regulation
Adenosine Triphosphatases
Up-Regulation
Messenger RNA
Pharmaceutical Preparations

Keywords

  • calcium
  • calpain
  • CDDP
  • ovarian cancer
  • p73a

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Al-Bahlani, S., Fraser, M., Wong, A. Y. C., Sayan, B. S., Bergeron, R., Melino, G., & Tsang, B. K. (2011). P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene, 30(41), 4219-4230. https://doi.org/10.1038/onc.2011.134

P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. / Al-Bahlani, S.; Fraser, M.; Wong, A. Y C; Sayan, B. S.; Bergeron, R.; Melino, G.; Tsang, B. K.

In: Oncogene, Vol. 30, No. 41, 13.10.2011, p. 4219-4230.

Research output: Contribution to journalArticle

Al-Bahlani, S, Fraser, M, Wong, AYC, Sayan, BS, Bergeron, R, Melino, G & Tsang, BK 2011, 'P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism', Oncogene, vol. 30, no. 41, pp. 4219-4230. https://doi.org/10.1038/onc.2011.134
Al-Bahlani, S. ; Fraser, M. ; Wong, A. Y C ; Sayan, B. S. ; Bergeron, R. ; Melino, G. ; Tsang, B. K. / P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. In: Oncogene. 2011 ; Vol. 30, No. 41. pp. 4219-4230.
@article{b37cd69d9748473daf9e70117894b36f,
title = "P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism",
abstract = "P73 is important in drug-induced apoptosis in some cancer cells, yet its role in the regulation of chemosensitivity in ovarian cancer (OVCA) is poorly understood. Furthermore, if and how the deregulation of p73-mediated apoptosis confers resistance to cisplatin (CDDP) treatment is unclear. Here we demonstrate that TAp73α over-expression enhanced CDDP-induced PARP cleavage and apoptosis in both chemosensitive (OV2008 and A2780s) and their resistant counterparts (C13 and A2780cp) and another chemoresistant OVCA cells (Hey); in contrast, the effect of ΔNp73α over-expression was variable. P73α downregulation attenuated CDDP-induced PUMA and NOXA upregulation and apoptosis in OV2008 cells. CDDP decreased p73α steady-state protein levels in OV2008, but not in C13, although the mRNA expression was identical. CDDP-induced p73α downregulation was mediated by a calpain-dependent pathway. CDDP induced calpain activation and enhanced its cytoplasmic interaction and co-localization with p73α in OV2008, but not C13 cells. CDDP increased the intracellular calcium concentration ([Ca 2[ i) in OV2008 but not C13 whereas cyclopiazonic acid (CPA), a Ca 2+-ATPase inhibitor, caused this response and calpain activation, p73α processing and apoptosis in both cell types. CDDP-induced [Ca 2+[ i increase in OV2008 cells was not effected by the elimination of extracellular Ca 2+, but this was attenuated by the depletion of internal Ca 2+ store, indicating that mobilization of intracellular Ca 2+] stores was potentially involved. These findings demonstrate that p73α and its regulation by the Ca 2+-mediated calpain pathway are involved in CDDP-induced apoptosis in OVCA cells and that dysregulation of Ca 2+/calpain/p73 signaling may in part be the pathophysiology of CDDP resistance. Understanding the cellular and molecular mechanisms of chemoresistance will direct the development of effective strategies for the treatment of chemoresistant OVCA.",
keywords = "calcium, calpain, CDDP, ovarian cancer, p73a",
author = "S. Al-Bahlani and M. Fraser and Wong, {A. Y C} and Sayan, {B. S.} and R. Bergeron and G. Melino and Tsang, {B. K.}",
year = "2011",
month = "10",
day = "13",
doi = "10.1038/onc.2011.134",
language = "English",
volume = "30",
pages = "4219--4230",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "41",

}

TY - JOUR

T1 - P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism

AU - Al-Bahlani, S.

AU - Fraser, M.

AU - Wong, A. Y C

AU - Sayan, B. S.

AU - Bergeron, R.

AU - Melino, G.

AU - Tsang, B. K.

PY - 2011/10/13

Y1 - 2011/10/13

N2 - P73 is important in drug-induced apoptosis in some cancer cells, yet its role in the regulation of chemosensitivity in ovarian cancer (OVCA) is poorly understood. Furthermore, if and how the deregulation of p73-mediated apoptosis confers resistance to cisplatin (CDDP) treatment is unclear. Here we demonstrate that TAp73α over-expression enhanced CDDP-induced PARP cleavage and apoptosis in both chemosensitive (OV2008 and A2780s) and their resistant counterparts (C13 and A2780cp) and another chemoresistant OVCA cells (Hey); in contrast, the effect of ΔNp73α over-expression was variable. P73α downregulation attenuated CDDP-induced PUMA and NOXA upregulation and apoptosis in OV2008 cells. CDDP decreased p73α steady-state protein levels in OV2008, but not in C13, although the mRNA expression was identical. CDDP-induced p73α downregulation was mediated by a calpain-dependent pathway. CDDP induced calpain activation and enhanced its cytoplasmic interaction and co-localization with p73α in OV2008, but not C13 cells. CDDP increased the intracellular calcium concentration ([Ca 2[ i) in OV2008 but not C13 whereas cyclopiazonic acid (CPA), a Ca 2+-ATPase inhibitor, caused this response and calpain activation, p73α processing and apoptosis in both cell types. CDDP-induced [Ca 2+[ i increase in OV2008 cells was not effected by the elimination of extracellular Ca 2+, but this was attenuated by the depletion of internal Ca 2+ store, indicating that mobilization of intracellular Ca 2+] stores was potentially involved. These findings demonstrate that p73α and its regulation by the Ca 2+-mediated calpain pathway are involved in CDDP-induced apoptosis in OVCA cells and that dysregulation of Ca 2+/calpain/p73 signaling may in part be the pathophysiology of CDDP resistance. Understanding the cellular and molecular mechanisms of chemoresistance will direct the development of effective strategies for the treatment of chemoresistant OVCA.

AB - P73 is important in drug-induced apoptosis in some cancer cells, yet its role in the regulation of chemosensitivity in ovarian cancer (OVCA) is poorly understood. Furthermore, if and how the deregulation of p73-mediated apoptosis confers resistance to cisplatin (CDDP) treatment is unclear. Here we demonstrate that TAp73α over-expression enhanced CDDP-induced PARP cleavage and apoptosis in both chemosensitive (OV2008 and A2780s) and their resistant counterparts (C13 and A2780cp) and another chemoresistant OVCA cells (Hey); in contrast, the effect of ΔNp73α over-expression was variable. P73α downregulation attenuated CDDP-induced PUMA and NOXA upregulation and apoptosis in OV2008 cells. CDDP decreased p73α steady-state protein levels in OV2008, but not in C13, although the mRNA expression was identical. CDDP-induced p73α downregulation was mediated by a calpain-dependent pathway. CDDP induced calpain activation and enhanced its cytoplasmic interaction and co-localization with p73α in OV2008, but not C13 cells. CDDP increased the intracellular calcium concentration ([Ca 2[ i) in OV2008 but not C13 whereas cyclopiazonic acid (CPA), a Ca 2+-ATPase inhibitor, caused this response and calpain activation, p73α processing and apoptosis in both cell types. CDDP-induced [Ca 2+[ i increase in OV2008 cells was not effected by the elimination of extracellular Ca 2+, but this was attenuated by the depletion of internal Ca 2+ store, indicating that mobilization of intracellular Ca 2+] stores was potentially involved. These findings demonstrate that p73α and its regulation by the Ca 2+-mediated calpain pathway are involved in CDDP-induced apoptosis in OVCA cells and that dysregulation of Ca 2+/calpain/p73 signaling may in part be the pathophysiology of CDDP resistance. Understanding the cellular and molecular mechanisms of chemoresistance will direct the development of effective strategies for the treatment of chemoresistant OVCA.

KW - calcium

KW - calpain

KW - CDDP

KW - ovarian cancer

KW - p73a

UR - http://www.scopus.com/inward/record.url?scp=80054023857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054023857&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.134

DO - 10.1038/onc.2011.134

M3 - Article

VL - 30

SP - 4219

EP - 4230

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 41

ER -